Hefei, China

Yijun Bao

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Hefei Blooming Drug Safety Evaluation Co., Ltd., Hefei Cosource Pharmaceuticals Inc.. Active years: 2020.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yijun Bao: Innovator in Natural Medicine

Introduction

Yijun Bao is a prominent inventor based in Hefei, China. He has made significant contributions to the field of natural medicine and pharmaceutical chemistry. His work focuses on developing innovative compounds that can address critical health issues.

Latest Patents

Yijun Bao holds a patent for a cycloartane tetracyclic triterpenoid compound, along with its preparation method and medical use. This invention is particularly relevant in the context of cardiovascular and cerebrovascular diseases. The pharmacodynamic tests indicate that the compound exhibits activity on heart and cerebral vessels, making it a potential treatment for conditions such as arrhythmia, myocardial infarction, and coronary heart disease.

Career Highlights

Throughout his career, Yijun Bao has worked with notable companies, including Hefei Cosource Pharmaceuticals Inc. and Hefei Blooming Drug Safety Evaluation Co., Ltd. His experience in these organizations has allowed him to advance his research and contribute to the development of effective medical solutions.

Collaborations

Yijun Bao has collaborated with several professionals in his field, including Shanchun Zhang and Shu Gao. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

Yijun Bao is a dedicated inventor whose work in natural medicine has the potential to improve health outcomes for many individuals. His innovative approaches and collaborations continue to drive advancements in pharmaceutical chemistry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…